A Systematic Evaluation of the Safety and Toxicity of Fingolimod for Its Potential Use in the Treatment of Acute Myeloid Leukaemia

Anti-Cancer Drugs - United States
doi 10.1097/cad.0000000000000358
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Razoxane in Treatment of Acute Myeloid Leukaemia.

BMJ
1978English

SOX12: A Novel Potential Target for Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2016English

8 Treatment of the Elderly Patient With Acute Myeloid Leukaemia

Baillière's Clinical Haematology
1996English

A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia

Frontiers in Pharmacology
Pharmacology
2019English

Treatment of Acute Myeloid Leukaemia in a Renal Allograft Recipient: Implications of Cyclosporin Immunosuppressive Treatment.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

A New Approach to the Treatment of Acute Myeloid Leukaemia Targeting the Receptor for Growth Hormone-Releasing Hormone

British Journal of Haematology
Hematology
2018English

Acute Aleukaemic Myeloid Leukaemia

BMJ
1943English

Cholecystitis as the Initial Presentation of Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2016English

Prognosis in Acute Myeloid Leukaemia.

BMJ
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy